U.S. health body questions AstraZeneca’s COVID-19 vaccine trial data

"Запомните, что не достичь успеха – иногда тоже большая удача." Далай Лама ©

By Miyoung Kim and Caroline Copley SINGAPORE (Reuters) — AstraZeneca may have released outdated information on its latest COVID-19 vaccine trial, giving an «incomplete» picture of its efficacy, a leading U.S. health agency said on Tuesday, casting doubt on the shot’s potential U.S. rollout and plunging its developers, once again, into controversy. The surprise public rebuke from federal health officials comes just one day after interim data from the drugmaker showed better-than-expected results from the U.S. trial. That had been seen as a scientific counter to concerns that have dogged the sho…

Read More

Related posts

Leave a Comment

18 + 9 =